Claims Analysis
Total Claims: 7
Claim 1
Independent Claim
199 words
A method of making an antigen albumen complex comprising the steps of: mixing, in acid solution, at a pH not exceeding about 5, the antigen, said antigen being: a cancer associated polypeptide antigen, obtained from a source selected from the group consisting of human tumor tissue, a culture of cancerous cells grown in vitro, and human placental tissue, having a molecular weight of 23,200 ± 2,500 (S.D.) and showing a spectrophotometric peak absorption at a wave length within the range from about 229 nm to about 233 nm, said polypeptide being based on a single peptide chain as shown by treatment with performic acid, said single peptide chain comprising the following amino acids: Alanine, Arginine, Aspartic acid, Cysteine, Glutamic acid, Glycine, Histidine, Isoleucine, Leucine, Lysine, Methionine, Phenylalanine, Serine, Threonine, Tyrosine, and Valine, said polypeptide antigen comprising also a fluoroescent group which emits fluorescent light at about 350 nm when activated at a wavelength of about 288 nm, and, if not protected by complexing with albumen, denaturating irreversibly at pH's exceeding about 5, and albumen, and raising the pH of the solution to about neutral to cause interaction between the components and production of a relatively stable antigen albumen complex.
Claim 2
Independent Claim
199 words
A method of making an antigen albumen complex comprising the steps of: mixing, in acid solution, at a pH not exceeding about 5, the antigen, said antigen being: a cancer associated polypeptide antigen, obtained from a source selected from the group consisting of human tumor tissue, a culture of cancerous cells grown in vitro, and human placental tissue, having a molecular weight of 23,200 ± 2,500 (S.D.) and showing a spectrophotometric peak absorption at a wave length within the range from about 229 nm to about 233 nm, said polypeptide being based on a single peptide chain as shown by treatment with performic acid, said single peptide chain comprising the following amino acids: Alanine, Arginine, Aspartic acid, Cysteine, Glutamic acid, Glycine, Histidine, Isoleucine, Leucine, Lysine, Methionine, Phenylalanine, Serine, Threonine, Tyrosine, and Valine, said polypeptide antigen comprising also a fluoroescent group which emits fluorescent light at about 350 nm when activated at a wavelength of about 288 nm, and, if not protected by complexing with albumen, denaturating irreversibly at pH's exceeding about 5, and albumen, and raising the pH of the solution to about neutral to cause interaction between the components and production of a relatively stable antigen albumen complex.
Claim 3
Dependent Claim
14 words
A method according to claim 1, including the further step of lyophilizing the complex.
Claim 4
Dependent Claim
169 words
A complex, useful as a stabilized antigen for diagnostic purposes, comprising: a cancer associated polypeptide antigen, obtained from a source selected from the group consisting of human tumor tissue, a culture of cancerous cells grown in vitro, and human placental tissue, havng a molecular weight of 23,200 ± 2,500 (S.D.) and showing a spectrophotometric peak absorption at a wave length within the range from about 229 nm to about 233 nm, said polypeptide being based on a single peptide chain as shown by treatment with performic acid, said single peptide chain comprising the following amino acids: Alanine, Arginine, Aspartic acid, Cysteine, Glutamic acid, Glycine, Histidine, Isoleucine, Leucine, Lysine, Methionine, Phenylalanine, Serine, Threonine, Tyrosine, and Valine, said polypeptide antigen comprising also a fluoroescent group which emits fluorescent light at about 350 nm when activated at a wavelength of about 288 nm, and if, not protected by complexing with albumen, denaturating irreversibly at pH's exceeding about 5, and a stabilizing amount of albumen complexed therewith by the method of claim 1.
Claim 5
Dependent Claim
22 words
The complex of claim 3, wherein the ratio of albumen to the antigen, is equal to about or exceeding 200:1 by weight.
Claim 6
Dependent Claim
15 words
A diagnostic composition comprising a particulate material labelled with the albumen-stabilized antigen of claim 3.
Claim 7
Dependent Claim
25 words
The diagnostic composition of claim 5, wherein the particulate material is selected from the group consisting of tanned red blood cells, latex bentonite and collodion.